Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B M Feldman

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
The Journal of Rheumatology|October 19, 2000
Intravenous immunoglobulin therapy for juvenile dermatomyositis: efficacy and safetyS M Al-Mayouf, R M Laxer, R Schneider, et al.
The Journal of Rheumatology|April 29, 1998
Cyclosporine in the treatment of an unusual case of juvenile systemic sclerosisS M al-Mayouf, E D Silverman, B M Feldman, et al.
Rheumatology (Oxford, England)|March 24, 2005
What does "active disease" mean? patient and parent perceptions of disease activity in the systemic arthritis form of juvenile idiopathic arthritis (SO-JIA)M Batthish, R Schneider, A V Ramanan, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 3, 2015
Assessments of outcome in haemophilia - what is the added value of QoL tools?H M van den Berg, B M Feldman, K Fischer, et al.
The Journal of Rheumatology|February 1, 1995
Measuring disability in juvenile dermatomyositis: validity of the childhood health assessment questionnaireB M Feldman, A Ayling-Campos, L Luy, et al.
European Journal of Cancer (Oxford, England : 1990)|March 27, 2007
Serial controlled N-of-1 trials of topical vitamin E as prophylaxis for chemotherapy-induced oral mucositis in paediatric patientsL Sung, G A Tomlinson, M L Greenberg, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 11, 2007
Definitions for haemophilia prophylaxis and its outcomes: the Canadian consensus studyS Ota, M Mclimont, M D Carcao, et al.
Statistics in Medicine|October 9, 2001
A three-stage clinical trial design for rare disordersV E Honkanen, A F Siegel, J P Szalai, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 7, 2005
Cost of severe haemophilia in TorontoH E Heemstra, T Zwaan, M Hemels, et al.
Arthritis and Rheumatism|February 24, 2010
Risk factors for development of uveitis differ between girls and boys with juvenile idiopathic arthritisR K Saurenmann, A V Levin, B M Feldman, et al.
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
The Journal of Rheumatology|October 19, 2000
Intravenous immunoglobulin therapy for juvenile dermatomyositis: efficacy and safetyS M Al-Mayouf, R M Laxer, R Schneider, et al.
The Journal of Rheumatology|April 29, 1998
Cyclosporine in the treatment of an unusual case of juvenile systemic sclerosisS M al-Mayouf, E D Silverman, B M Feldman, et al.
Rheumatology (Oxford, England)|March 24, 2005
What does "active disease" mean? patient and parent perceptions of disease activity in the systemic arthritis form of juvenile idiopathic arthritis (SO-JIA)M Batthish, R Schneider, A V Ramanan, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 3, 2015
Assessments of outcome in haemophilia - what is the added value of QoL tools?H M van den Berg, B M Feldman, K Fischer, et al.
The Journal of Rheumatology|February 1, 1995
Measuring disability in juvenile dermatomyositis: validity of the childhood health assessment questionnaireB M Feldman, A Ayling-Campos, L Luy, et al.
European Journal of Cancer (Oxford, England : 1990)|March 27, 2007
Serial controlled N-of-1 trials of topical vitamin E as prophylaxis for chemotherapy-induced oral mucositis in paediatric patientsL Sung, G A Tomlinson, M L Greenberg, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 11, 2007
Definitions for haemophilia prophylaxis and its outcomes: the Canadian consensus studyS Ota, M Mclimont, M D Carcao, et al.
Statistics in Medicine|October 9, 2001
A three-stage clinical trial design for rare disordersV E Honkanen, A F Siegel, J P Szalai, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 7, 2005
Cost of severe haemophilia in TorontoH E Heemstra, T Zwaan, M Hemels, et al.
Arthritis and Rheumatism|February 24, 2010
Risk factors for development of uveitis differ between girls and boys with juvenile idiopathic arthritisR K Saurenmann, A V Levin, B M Feldman, et al.
Pageof 9